Skip to main content
SSY Group Limited logo

SSY Group Limited — Investor Relations & Filings

Ticker · 2005 ISIN · KYG8406X1034 HKEX Manufacturing
Open in API
Filings indexed 1,214 across all filing types
Latest filing 2022-02-09 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2005

About SSY Group Limited

http://www.ssygroup.com.hk

SSY Group Limited is an investment holding company specializing in the research, development, manufacturing, and sale of pharmaceutical products. The Group is a prominent manufacturer, with a core focus on producing a wide range of intravenous infusion solutions and finished drugs. Complementing its pharmaceutical offerings, the company also manufactures essential packaging materials, including non-PVC soft bags and PP plastic containers. SSY Group supplies its comprehensive product line, which often utilizes green production technologies aimed at reducing costs and power consumption, primarily to hospitals and medical institutions.

Recent filings

Filing Released Lang Actions
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement from the board of directors providing an update on product development, specifically the approval for drug production and registration. It is not a financial report, earnings release, or regulatory filing related to financial performance. The document is short (1945 characters) and serves to inform shareholders and investors about business developments rather than detailed financial data or governance changes. It does not fit into categories like Annual Report, Interim Report, or Management Reports. It is an announcement of business progress, which aligns best with the Regulatory Filings (RNS) category as a general regulatory announcement that does not fit other specific categories.
2022-02-09 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return regarding movements in securities for SSY Group Limited, including authorized share capital, issued shares, share options, repurchases, and confirmations related to securities issued. It is addressed to the Hong Kong Exchanges and Clearing Limited and references compliance with the Exchange Listing Rules. The content focuses on share capital changes, share repurchases, and confirmations by the company secretary. There are no financial statements, earnings data, or management discussion of financial results. The document is regulatory in nature, reporting share capital movements and confirmations to the stock exchange, which fits the category of a Regulatory Filing (RNS). It is not an announcement of a report, nor a full financial report or earnings release. Therefore, the appropriate classification is Regulatory Filings (RNS).
2022-02-04 English
POSSIBLE SPIN-OFF AND SEPARATE QUOTATION OF JIANGSU BEST NEW MEDICAL ON THE NEEQ
Regulatory Filings Classification · 95% confidence The document is an announcement made by the board of directors regarding a possible spin-off and separate quotation of a subsidiary company on the National Equities Exchange and Quotations (NEEQ). It references previous announcements and regulatory compliance with the Listing Rules of the Hong Kong Stock Exchange. The document discusses procedural details, regulatory waivers, and the status of the spin-off application but does not contain financial statements or detailed financial data. It is an official announcement informing shareholders and the market about the spin-off process and related regulatory matters. The document length is about 5983 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits best into the category of a Regulatory Filing (RNS), as it is a general regulatory announcement that does not fit into more specific categories like Capital/Financing Update or M&A Activity, since it is about a possible spin-off and related regulatory compliance but not a completed transaction or detailed financial report.
2022-01-28 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by SSY Group Limited. It includes detailed information on repurchases of shares, dates, prices, and confirmations that the repurchases were made in accordance with listing rules. The document is a regulatory disclosure about share repurchases, not a full financial report or earnings release. It fits the description of a 'Transaction in Own Shares' report, which covers company buybacks or sales of its own shares. The document length (10,143 characters) and detailed transactional data support this classification rather than a brief announcement or a general regulatory filing.
2022-01-27 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by SSY Group Limited. It includes detailed information on repurchases of shares, dates, quantities, prices, and confirmations of compliance with listing rules. The document is a regulatory disclosure about share capital changes and repurchases, not a full financial report or earnings release. It is not a report publication announcement since it contains substantive data. The content fits the category of Transaction in Own Shares (POS), which covers company buybacks or sales of its own shares.
2022-01-25 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by SSY Group Limited. It includes detailed information about repurchase of shares, dates, prices, and confirmations of compliance with listing rules on the Stock Exchange of Hong Kong. The content focuses on reporting share repurchase activity and changes in capital structure rather than announcing a new report or providing financial results. This matches the description of a 'Transaction in Own Shares' filing, which reports company buybacks or sales of its own shares. The document length is sufficient and contains substantive data about the share repurchase transaction, not just an announcement or certification. Therefore, the correct classification is POS (Transaction in Own Shares).
2022-01-24 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.